United States · FDA National Drug Code directory

verapamil hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70518-1326_53329ce0-d237-2414-e063-6294a90a71be
Product NDC: 70518-1326
Form: TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term: verapamil hydrochloride
Labeler: REMEDYREPACK INC.
Marketing category: ANDA
Marketing start / end (source format): 20180726
Source listing expiry: 20271231

Source-listed ingredients

VERAPAMIL HYDROCHLORIDE — 240 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-1326-0) · 70518-1326-0
50 POUCH in 1 BOX (70518-1326-1) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 POUCH (70518-1326-2) · 70518-1326-1
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-1326-3) · 70518-1326-3

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →